Dimensional Fund Advisors
PCRX icon

Dimensional Fund Advisors’s Pacira BioSciences PCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$51.4M Buy
2,151,642
+102,211
+5% +$2.44M 0.01% 1481
2025
Q1
$50.9M Buy
2,049,431
+217,215
+12% +$5.4M 0.01% 1468
2024
Q4
$34.5M Sell
1,832,216
-40,154
-2% -$757K 0.01% 1728
2024
Q3
$28.2M Buy
1,872,370
+44,305
+2% +$667K 0.01% 1831
2024
Q2
$52.3M Buy
1,828,065
+198,936
+12% +$5.69M 0.01% 1432
2024
Q1
$47.6M Buy
1,629,129
+217,362
+15% +$6.35M 0.01% 1486
2023
Q4
$47.6M Buy
1,411,767
+17,949
+1% +$606K 0.01% 1484
2023
Q3
$42.8M Buy
1,393,818
+271,544
+24% +$8.33M 0.01% 1456
2023
Q2
$45M Buy
1,122,274
+133,097
+13% +$5.33M 0.01% 1433
2023
Q1
$40.4M Buy
989,177
+41,808
+4% +$1.71M 0.01% 1489
2022
Q4
$36.6K Buy
947,369
+70,141
+8% +$2.71K 0.01% 1516
2022
Q3
$46.7M Buy
877,228
+67,892
+8% +$3.61M 0.02% 1285
2022
Q2
$47.2M Buy
809,336
+50,941
+7% +$2.97M 0.02% 1331
2022
Q1
$57.9M Buy
758,395
+3,602
+0.5% +$275K 0.02% 1295
2021
Q4
$45.4M Buy
754,793
+40,191
+6% +$2.42M 0.01% 1483
2021
Q3
$40M Sell
714,602
-68,290
-9% -$3.82M 0.01% 1576
2021
Q2
$47.5M Buy
782,892
+169,324
+28% +$10.3M 0.02% 1490
2021
Q1
$43M Buy
613,568
+37,851
+7% +$2.65M 0.01% 1563
2020
Q4
$34.4M Buy
575,717
+18,553
+3% +$1.11M 0.01% 1664
2020
Q3
$33.5M Buy
557,164
+12,857
+2% +$773K 0.01% 1515
2020
Q2
$28.6M Buy
544,307
+15,972
+3% +$838K 0.01% 1642
2020
Q1
$17.7M Buy
528,335
+22,550
+4% +$756K 0.01% 1828
2019
Q4
$22.9M Buy
505,785
+2,941
+0.6% +$133K 0.01% 1963
2019
Q3
$19.1M Buy
502,844
+77,525
+18% +$2.95M 0.01% 2044
2019
Q2
$18.5M Buy
425,319
+73,207
+21% +$3.18M 0.01% 2094
2019
Q1
$13.4M Buy
352,112
+111,505
+46% +$4.24M 0.01% 2270
2018
Q4
$10.4M Buy
240,607
+180,425
+300% +$7.76M ﹤0.01% 2327
2018
Q3
$2.96M Buy
+60,182
New +$2.96M ﹤0.01% 2825
2015
Q2
Sell
-46,790
Closed -$4.16M 3369
2015
Q1
$4.16M Sell
46,790
-3,270
-7% -$291K ﹤0.01% 2624
2014
Q4
$4.44M Buy
50,060
+22,094
+79% +$1.96M ﹤0.01% 2600
2014
Q3
$2.71M Buy
27,966
+19,962
+249% +$1.93M ﹤0.01% 2762
2014
Q2
$735K Buy
+8,004
New +$735K ﹤0.01% 3103